Article
Rationalizing Heterogeneity in Staphylococcus aureus Bacteremia: Current Progress and Future Goals.
The Journal of infectious diseases - 23 Sept 2026
Russell Clark D, De La Villa Sofía, Swets Maaike C, Westgeest Annette C, Zumbo Giulia, Muñoz Patricia, Dockrell David H, Fowler Vance G, Gutiérrez-Gutiérrez Belén
Abstract excerpt
Clinical and biological heterogeneity in Staphylococcus aureus bacteremia (SAB) continue to pose significant challenges for the clinical management of individual patients and for research efforts. We contend that investigating SAB as a single disease is impeding the identification of beneficial therapeutic approaches. Recently, three data-driven approaches for patient stratification in SAB have been reported,...
Read the complete abstract on PubMedTopics
- Humans
- Staphylococcal Infections
- Bacteremia
- Staphylococcus aureus
- Anti-Bacterial Agents
- Phenotype
